Venture Portfolio - Proclara Biosciences

PROCLARA Biosciences

Key figures

  • 2008
    Creation Date
  • 18
    Number of Employees
  • 2011
    Investment Date
  • Mérieux Participations 1
    Fund Name

Company presentation

Proclara Biosciences is pioneering a new approach to treating neurodegenerative diseases.

By developing novel therapies that recognize and target multiple misfolded proteins, they aim to make a transformative impact on the lives of patients affected by Alzheimer’s, Parkinson’s, and other diseases caused by protein misfolding.

Their approach is shaped by an experienced team with deep drug development experience, and productive collaborations with world-class advisors and partners.


222, Third Street - MA 02142 Cambridge - USA

Key contacts